A detailed history of Rakuten Investment Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Rakuten Investment Management, Inc. holds 30,633 shares of MRNA stock, worth $724,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,633
Holding current value
$724,470
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$28.35 - $47.53 $868,445 - $1.46 Million
30,633 New
30,633 $868,000
Q3 2024

May 15, 2025

BUY
$63.64 - $125.14 $464,635 - $913,647
7,301 Added 35.82%
27,681 $1.85 Million
Q2 2024

May 15, 2025

BUY
$101.21 - $166.61 $795,713 - $1.31 Million
7,862 Added 62.81%
20,380 $2.42 Million
Q1 2024

May 15, 2025

BUY
$85.37 - $115.44 $999,170 - $1.35 Million
11,704 Added 1437.84%
12,518 $1.33 Million
Q4 2023

May 15, 2025

SELL
$69.51 - $104.43 $2.07 Million - $3.11 Million
-29,819 Reduced 97.34%
814 $80,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.25B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Rakuten Investment Management, Inc. Portfolio

Follow Rakuten Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Investment Management, Inc. with notifications on news.